Articles From: ideeli Becomes ideel to IDM Mining Advances Permitting of Red Mountain Gold Project


2014/8/14
ideeli, the online retailer, announced it has officially become ideel .
Sign-up for ideeli Becomes ideel investment picks
CAMBRIDGE, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) , a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported unaudited financial results for the second quarter ended June 30, 2014.
Sign-up for Idenix Pharmaceuticals Reports Second Quarter and Six Month 2014 Financial Results investment picks
2014/9/29
Security related topics are often front and center in the 24-hour news cycle, but what concerns Americans the most?
Sign-up for Identity Theft, Personal Cybersecurity and Terrorism Top the List of Americans’ Security Concerns, Finds University of Phoenix Survey investment picks
FREMONT, Calif., Sept.
Sign-up for Identiv Announces Proposed Public Offering of Common Stock investment picks
FREMONT, Calif., Sept.
Sign-up for Identiv CEO Jason Hart to Present Update at AGC's Boston Technology Growth Conference investment picks
FREMONT, Calif., Sept.
Sign-up for Identiv Closes $30 Million Public Offering of Common Stock investment picks
FREMONT, Calif., Oct.
Sign-up for Identiv Launches October uTrust Webinar Series investment picks
FREMONT, Calif., Sept.
Sign-up for Identiv Launches uTrust Technology Partnership Program With Viscount Systems as First Member investment picks
FREMONT, Calif., Sept.
Sign-up for Identiv Prices $30 Million Public Offering of Common Stock investment picks
Quarterly Revenue of $22.3 Million Up 23 Percent Year over Year FREMONT, Calif., Aug.
Sign-up for Identiv Reports Q2 2014 Earnings investment picks
FREMONT, Calif., Sept.
Sign-up for Identiv to Establish Trust in the Connected World With uTrust Verge Product Line at ASIS 2014 investment picks
FREMONT, Calif., Aug.
Sign-up for Identiv to Hold Q2 2014 Earnings Webcast and Conference Call on August 13, 2014 investment picks
FREMONT, Calif., Nov.
Sign-up for Identiv to Hold Q3 2014 Earnings Webcast and Conference Call on November 13, 2014 investment picks
Toll-like receptor antagonism designed to treat muscle inflammation central to disease progression New approach offers potential to treat broad population of patients regardless of their genetic mutation CAMBRIDGE, Mass.
Sign-up for Idera Pharmaceuticals and Parent Project Muscular Dystrophy Announce Collaboration to Advance New Treatment Approach for Duchenne Muscular Dystrophy investment picks
- IND application for Phase 1 clinical trial of IMO-9200 in healthy volunteers accepted by FDA; patient dosing on track to begin in fourth quarter CAMBRIDGE, Mass., Oct.
Sign-up for Idera Pharmaceuticals Expands Pipeline by Initiating Clinical Development of Proprietary TLR Antagonist Candidate IMO-9200 investment picks
-- Enrollment achieved in first two dose cohorts of Phase 1/2 Waldenstrom's trial -- Myositis program advanced with specification of Phase 2 clinical trial plan in dermatomyositis --
Sign-up for Idera Pharmaceuticals Reports Third Quarter Financial Results and Announces Expansion of Rare Disease Development Portfolio investment picks
IDEX CORPORATION (NYSE:IEX) today announced its Board of Directors has approved an additional share repurchase authorization of up to $400 million of IDEX’s outstanding common shares.
Sign-up for IDEX Corporation Announces Additional Share Repurchase Authorization investment picks
IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.28 per common share.
Sign-up for IDEX Corporation Declares Regular Quarterly Cash Dividend investment picks
IDEX CORPORATION (NYSE: IEX) announced today that it has scheduled the broadcast of the company’s third quarter earnings conference call over the Internet on Tuesday, October 21st at 9:30 a.m. CT.
Sign-up for IDEX Corporation to Webcast Third Quarter 2014 Earnings Call investment picks
IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended September 30, 2014.
Sign-up for IDEX Reports Third Quarter EPS of 88 Cents with Full Year EPS Guidance of $3.52 – $3.55 investment picks
- IDEXX selects UPS to support its US all-direct product distribution capability, providing IDEXX a cost effective, logistics solution for the entire continental US - IDEXX opens significantly expanded US direct customer sales center, offers free shipping and next day delivery for IDEXX direct orders; on track for 100% direct order and fulfillment capability over the course of Q4 - Strong business growth momentum continues in the US Companion Animal Group, reflected in continued strong veterinary diagnostic instrument placements in Q3 - Company announces expectation for earlier reduction of distributor inventories and reduced transitional impacts WESTBROOK, Maine , Oct.
Sign-up for IDEXX Announces Several Milestones in its US All-Direct CAG Distribution Strategy investment picks
- Delivers 11% normalized organic revenue growth and $1.05 Adjusted EPS, driven by strong growth in all business segments and regions including 12% normalized organic growth in CAG Diagnostics recurring revenues - Catalyst® and hematology instrument placements both increased over 30% in US and international markets - Transition to all-direct sales strategy in the US on track for 100% direct order and fulfillment capability in Q4 - Company announces launch of Catalyst One™, the Company's next generation chemistry analyzer, with customer shipments beginning November 3 - Strong business momentum supports increase in 2014 Adjusted EPS guidance to $3.85 to $3.90 and preliminary 2015 outlook for 13% to 14% normalized organic revenue growth and $4.38 to $4.48 Adjusted EPS WESTBROOK, Maine , Oct.
Sign-up for IDEXX Laboratories Announces Third Quarter Results investment picks
WESTBROOK, Maine , Sept.
Sign-up for IDEXX Laboratories Names Jacqueline L. Studer Corporate Vice President and General Counsel investment picks
WESTBROOK, Maine , Oct.
Sign-up for IDEXX Laboratories to Release 2014 Third Quarter Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977049001&sourceType=1 http://media3.marketwire.com/logos/20140613-IDM200.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for IDM Mining Advances Permitting of Red Mountain Gold Project investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: ideeli Becomes ideel to IDM Mining Advances Permitting of Red Mountain Gold Project
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent